Topics:
Breast Cancer • Medical Oncology
When would you consider adjuvant fulvestrant for ER+ breast cancer if the patient does not tolerate tamoxifen or any of the AIs?
Answer from: Medical Oncologist at Community Practice
While there are no trials that have assessed adjuvant fulvestrant versus placebo, we know from a small trial (GEICAM 2006-2010) that adjuvant fulvestrant plus anastrozole doesn’t add much when compared to adjuvant anastrozole. In this clinical setting, if the risk for distant recurrence is ver...
Sign in or Register to read more
Answer from: Medical Oncologist at Community Practice
I have not thought about it or done it yet